Vietnam Bans Two Hepatitis B Vaccines After Deaths Of Babies
This article was originally published in PharmAsia News
Vietnam's Ministry of Health ordered a ban on a pair of vaccines against hepatitis B after at least two babies died following injections. Samples of the vaccine have been sent to the Institute of Drug Quality Control for testing, the director of the ministry's pharmaceutical management department said. The drugs reportedly had been made by the National Institute of Hygiene and Epidemiology and its Vibiotech subsidiary. The ministry, which is looking into the two deaths, plans to ask LG of South Korea and Vaccine and Biological Products of Vietnam to inspect their vaccines for hepatitis vaccine and for diphtheria, pertussis and tetanus. (Click here for more
You may also be interested in...
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Hikma has pushed back against a further attempt by Amarin to counter its US generic version of Vascepa, this time via a fresh lawsuit claiming that the generic induces infringement of patents protecting cardiovascular indications for which the brand is approved but which are carved out of the generic label.
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.